Petadolex 75

Name: Petadolex 75
Brand: Linpharma

BrandLinpharma→Botanical Capsule 7 ingredients 1 banned DSLD #175545

Net contents: 60 Capsule(s)

Target: Adults and Children 4 years and above

DSLD entry: 2018-04-25

2 Ingredients (7)

IngredientGroupSafety

Purple Butterbur root extractButterburBanned in ≥1 country

Medium-Chain TriglyceridesMedium chain triglycerides (MCT)—

GelatinGelatin—

GlycerolGlycerol—

SorbitolSorbitol—

Olive OilOlive Oil—

Natural Mixed Carotenoidscarotenoids—

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

⛔ Contains an ingredient banned in ≥1 country

Butterbur 🇬🇧 🇨🇦 🇪🇺 🇦🇺 — Banned in herbal medicines due to PA hepatotoxicity risk.

3 Safety cross-reference

Butterbur — Banned in ≥1 country

⚠ Raw plant contains PYRROLIZIDINE ALKALOIDS — hepatotoxic

⚠ ONLY PA-free standardized extracts (Petadolex®) are acceptable

4 Label claims

• All Other

• Structure/Function

5 Data source

DSLD ID175545

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2018-04-25

6 More from Linpharma

View Linpharma Safety Scorecard → 2 products

Petadolex

7 Cite this page

Vancouver

Pkhakadze G. Petadolex 75 — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 17]. Available from: https://supplement.ge/products/petadolex-75-175545/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG